1-14 of 14
Arielle Baim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice

James E Thompson, Yan Gao, Alexis Visotcky, Kathryn E Flynn, Michael Mauro, Emily Giever, Arielle Baim, Idayat Akinola, Richard Larson, Omer Jamy, Anthony M. Hunter, Vamsi K. Kota, Jorge Cortes, Brian J. Druker, Neil P. Shah, Javier Pinilla-Ibarz, Jay Yang, Ellen K. Ritchie, Lindsay A.M Rein, B. Douglas Smith, Srinivas K. Tantravahi, Talha Badar, Michael W. Deininger, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 7420.
https://doi.org/10.1182/blood-2023-179963
Published: 2023
Journal Articles

A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with CD38 Expressing Relapsed/Refractory Acute Myeloid Leukemia

Guru Subramanian Guru Murthy, Jessica T. Leonard, Talha Badar, Cecilia Y. Arana Yi, Adam S Duvall, Bijal D. Shah, Arielle Baim, Tyce Kearl, Alexandra M. Harrington, Aniko Szabo, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 1541.
https://doi.org/10.1182/blood-2023-187721
Published: 2023
Journal Articles

A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Guru Subramanian Guru Murthy, Bijal D. Shah, Adam S Duvall, Jessica T. Leonard, Talha Badar, Cecilia Y. Arana Yi, Tyce Kearl, Arielle Baim, Alexandra M. Harrington, Aniko Szabo, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4242.
https://doi.org/10.1182/blood-2023-187468
Published: 2023
Journal Articles

HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice

Michael Mauro, Ehab L. Atallah, James E Thompson, Yan Gao, Alexis Visotcky, Emily Giever, Arielle Baim, Idayat Akinola, Richard A. Larson, Omer Jamy, Jorge Cortes, Brian J. Druker, Neil P. Shah, Javier Pinilla-Ibarz, Jay Yang, Ellen K. Ritchie, Lindsay A.M Rein, Srinivas K. Tantravahi, Talha Badar, B. Douglas Smith, Michael W. Deininger, Kathryn E Flynn
Journal: Blood
Blood (2023) 142 (Supplement 1): 7434.
https://doi.org/10.1182/blood-2023-188683
Published: 2023
Journal Articles

Treatment Free Remission after Combination Therapy with Asciminib (ABL001) Plus Imatinib in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed after a Prior Attempt at TKI Discontinuation-H Jean Khoury Cure CML Consortium Study

Michael Mauro, Alexis Visotcky, Kathryn E Flynn, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Jorge E. Cortes, Vamsi K Kota, Srinivas K. Tantravahi, Arielle Baim, Mei-Jie Zhang, Alexander Hinman, Ehab L. Atallah, Kendra Sweet
Journal: Blood
Blood (2022) 140 (Supplement 1): 6765–6766.
https://doi.org/10.1182/blood-2022-160138
Published: 2022
Journal Articles

Asciminib As Initial Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)-H. Jean Khoury Cure CML Consortium Study

Ehab L. Atallah, Alexis Visotcky, Kathryn E Flynn, Mei-Jie Zhang, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Srinivas K. Tantravahi, B. Douglas Douglas Smith, Javier Pinilla Ibarz, Kendra Sweet, Michael Mauro, Brian J. Druker, James E. Thompson, Sonia Maldonado-Schmidt, Arielle Baim, Charles A. Schiffer, Vamsi K. Kota, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 3885–3886.
https://doi.org/10.1182/blood-2022-160172
Published: 2022
Journal Articles

A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma

Guru Subramanian Guru Murthy, Tyce J Kearl, Weiguo Cui, Bryon Johnson, Karin Hoffmeister, Aniko Szabo, Kazuhiro Aoki, Alexandra M. Harrington, Karen Carlson, Laura C. Michaelis, Lyndsey Runaas, Sameem Abedin, Adam S Duvall, Wendy Stock, Bijal D. Shah, Jessica Leonard, Keith W. Pratz, Selina M. Luger, Talha Badar, Arielle Baim, Shahriar Yaghoubi, Ehab L. Atallah
Journal: Blood
Blood (2021) 138 (Supplement 1): 4401.
https://doi.org/10.1182/blood-2021-149329
Published: 2021
Journal Articles

Second Treatment Free Remission after Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CML)

Kendra Sweet, Ehab L. Atallah, Jerry P. Radich, Mei-Jie Zhang, Eva Sahakian, Melanie Mediavilla-Varela, Alexis Vistocky, Michael C. Heinrich, James E. Thompson, Michael J. Mauro, Kathryn E Flynn, Arielle Baim, Javier Pinilla Ibarz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2555.
https://doi.org/10.1182/blood-2021-147954
Published: 2021
Journal Articles

A Phase I Study of Pevonedistat, Azacitidine and Venetoclax for Patients with Relapsed/Refractory Acute Myelogenous Leukemia (AML)

Guru Subramanian Guru Murthy, Scott H. Kaufmann, Aniko Szabo, Alexandra M. Harrington, Laura C. Michaelis, Sameem Abedin, Karen Carlson, Lyndsey Runaas, Walter L. Longo, Alexander Hinman, Sonia Maldonado-Schmidt, Althea Thomas, Arielle Baim, Mark R. Litzow, Ehab L. Atallah
Journal: Blood
Blood (2021) 138 (Supplement 1): 2347.
https://doi.org/10.1182/blood-2021-149351
Published: 2021
Journal Articles

Building a National CML Registry

Ehab L. Atallah, MD, Arun K Singavi, MD, Bradley Taylor, Arielle Baim, Judith Myers, Emily Giever, Joan Neuner, MD, Bronwen E. Shaw, MD PhD, Kathryn E Flynn, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3440.
https://doi.org/10.1182/blood-2019-130358
Published: 2019
Journal Articles

A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)

Guru Subramanian Guru Guru Murthy, MBBS, Scott H. Kaufmann, MD PhD, Aniko Szabo, PhD, Arielle Baim, Ashish Anshu, Alexander Hinman, Laura C. Michaelis, MD, Sameem Abedin, MD, Karen-Sue B. Carlson, MD PhD, Lyndsey Runaas, MD, Ehab L. Atallah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3837.
https://doi.org/10.1182/blood-2019-131728
Published: 2019
Journal Articles

Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey

Gemlyn George, MD, Ehab L. Atallah, MD, Michael J. Mauro, MD, Stuart L. Goldberg, MD, Arielle Baim, Jessica Guhl, Alexander Hinman, Jorge E. Cortes, MD, Michael W. Deininger, MD PhD, Brian J. Druker, MD, Vamsi K Kota, Richard A. Larson, MD, Jeffrey H. Lipton, MD PhD, Joseph O. Moore, MD, Vivian G. Oehler, MD, Javier Pinilla Ibarz, MD, Jerald Radich, MD, Ellen K. Ritchie, MD, Charles A. Schiffer, MD, Neil P. Shah, MD PhD, Richard T. Silver, MD, Kendra L. Sweet, MD, James E. Thompson, MD, Martha Wadleigh, MD, Kathryn E Flynn, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5843.
https://doi.org/10.1182/blood-2018-99-114589
Published: 2018
Journal Articles

Results from the U.S. Life after Stopping TKIs (LAST) Study

Ehab Atallah, MD, Charles A. Schiffer, MD, Jerald P. Radich, MD, Kevin Weinfurt, PhD, Mei-Jie Zhang, PhD, Vamsi Kota, MBBS, Javier Pinilla-Ibarz, MD PhD, Joseph O. Moore, MD, Richard A. Larson, MD, Vivian Oehler, MD, Michael J. Mauro, MD, Michael W. Deininger, MD PhD, James E. Thompson, MD, Neil P. Shah, MD PhD, Martha Wadleigh, MD, Ellen K Ritchie, MD, Richard T Silver, MD, Jorge E. Cortes, MD, Arielle Baim, Mary M. Horowitz, MD MS, Kathryn Flynn, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2903.
https://doi.org/10.1182/blood.V130.Suppl_1.2903.2903
Published: 2017
Journal Articles

Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Ehab Atallah, MD, Laura C Michaelis, MD, Karen B. Carlson, MD PhD, Anita D'Souza, MBBS, MD, Timothy S. Fenske, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD, Arielle Baim, Jessica Guhl, Hari Parameswaran, MD
Journal: Blood
Blood (2016) 128 (22): 5192.
https://doi.org/10.1182/blood.V128.22.5192.5192
Published: 2016